рофессиональная
библиотека

Литература до 2000 года

Б

Белкина Б.М., Дурнов Л.А., Поляков В.Г., Голдобенко Г.В., Глеков И.В. Лечебная тактика и результаты комплексного лечения ретинобластомы у детей в распространенных стадиях заболевания. М., «Вопросы онкологии». 1997. №4. С. 435-439.
Ссылка

Боброва Н.Ф., Смалюх Н.В., Сухоедова Л.А. и др. Распространенность ретинобластомы у детей по различным областям Украины // Офтальмологический журнал. 1993. № 1. С. 21-23.

Бровкина А.Ф. Результаты лечения ретинобластомы. /А.Ф. Бровкина, О.Г. Пантелеева// Вестник офтальмологии. 1995. №3.

Д

Дурнов Л.А. Злокачественные опухоли у детей раннего возраста. М.: Медицина, 1984. 256 с.

К

Котелянский Э.О. Внутриглазные опухоли. М., 1974. 223 с.

П

Пантелеева О.Г. Ретинобластома: прогностическая значимость клинических симптомов, эффективность комбинированного лечения: автореф. дис… канд. мед.наук. М., 1997. 24 с.

Х

Хватова А.В., Вайнштейн Е.С., Дмитровcкая И.Н., Бурдянская Е.И. Диагностика и лечение ретинобластом у детей // Методические рекомендации. Москва 1980.

Хватова А.В., Вайнштейн Е.С., Дмитровская И.Н. и др. Отдаленные результаты комбинированного лечения ретинобластомы у детей. Вестник офтальмологии. 1976. №2. С.41-44.

Ш

Шиф Л.В. Глазное протезирование. М., 1981
A

Abramson D.H., Frank C.M. Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk.// Ophthalmology, 1998, vol.105, №4, pp.573-57.
DOI: 10.1016/S0161-6420(98)94006-4
https://www.ncbi.nlm.nih.gov/pubmed/9544627

Abramson D.H. Gerardi C.M. Ellsworth R.M. McCormic B. et all. Radiation Regression Patterns in Treated Retinoblastoma: 7 to 21 Years Later. Journal of Pediatric Ophthalmology & StrabismusVol. 28, No. 2. May, 1991
https://doi.org/10.3928/0191-3913-19910301-12
https://journals.healio.com/doi/10.3928/0191-3913-19910301-12

B

Berry J.L., Xu L., Polski A., Jubran R., Kuhn P., Kim J.W., Hicks J. Aqueous humor is superior to blood as a liquid biopsy for retinoblastoma. 2020, Ophthalmology, 2020 127, 552–554. https://doi.org/10.1016/j.ophtha.2019.10.026

Broome C.B., Schiff R.I., Friedman H.S. Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions. Med. Pediatr. Oncol. 1996. Vol.26, №2. P.105-10.
DOI: 10.1002/(SICI)1096-911X(199602)26:2<105::AID-MPO7>3.0.CO;2-P
https://pubmed.ncbi.nlm.nih.gov/8531847/

C

Cassady J.R., Sagerman R.H., Tretter P., Ellsworth R.M. Radiation therapy in retinoblastoma. An analysis of 230 cases. Radiology. 1969 Aug;93(2):405-9. PMID: 5822720
doi: 10.1148/93.2.405

Chan H.S., DeBoer G., Thiessen J.J. et al. Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without requiring radiation. Clin. Cancer Res. 1996. Vol.2, №9. P.1499-1508
https://pubmed.ncbi.nlm.nih.gov/9816326/

Chantada G., Fandino A., Manzitti J. et al. Late diagnosis of retinoblastoma in a developing country // Archives of Disease in Childhood. 1999. Vol. 80. P. 171-174
DOI: 10.1136/adc.80.2.171
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1717843/

D

Derkinderen D., Koten J. Early diagnosis of retinoblastoma reduced death and blindness // Int. J. Cancer. 1989. Vol. 44. P. 35-39. Derкinderen D.J., Koten J.W., Tan K.E. et al. Parental age in sporadic hereditary retinoblastoma // American Journal of Ophthalmology. 1990. Vol. 110. P. 605-609
DOI: 10.1016/s0002-9394(14)77056-4
https://www.ncbi.nlm.nih.gov/pubmed/2248323

Desjardins L., Levy C., Labib A., Schlienger P., Putterman M., Zucker J.M., Rosenwald J.C., Haye C., Validire P. An Experience of the Use of Radioactive Plaques after Failure of External Beam Radiation in the Treatment of Retinoblastoma. Ophthalmic Paediatr Genet 1993; 14(1):39–42
doi: 10.3109/13816819309087622

Draper G., Sanders B., Brownhill P., Hawkins M. Patterns of risk of hereditary retinoblastoma and applications to genetic counselling // British Journal of Cancer. 1992. Vol. 66. P. 211-219
DOI: 10.1038/bjc.1992.244
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977909/

Dryja T.P., Morrow J.F., Rapaport J.M. Quantification of the paternal allele bias for new germline mutations in the retinoblastoma gene // Human Genetics. 1997. Vol. 100. P. 446-449
DOI: 10.1007/s004390050531
https://www.ncbi.nlm.nih.gov/pubmed/9272170

Dunphy E.B. The story of retinoblastoma. Trans Am Acad Ophthalmol Otolaryngol 1964; 68:249–64
PMID: 14130932

E

Eng C., Li F.P., Abramson D.H. et al. Mortality from second tumors among long-term survivors of retinoblastoma. J. Natl. Cancer Inst. 1993. Vol.85, №14. P.1121–8
DOI: 10.1093/jnci/85.14.1121
https://pubmed.ncbi.nlm.nih.gov/8320741/

Ericson L.A., Rosengren B.H. Present therapeutic resources in retinoblastoma. Acta Ophthalmol (Copenh.). 1961. Vol.39. P.569 – 576
doi: 10.1111/j.1755-3768.1961.tb00269.x
https://pubmed.ncbi.nlm.nih.gov/13890561/

Ericson L., Karlberg B., Rosengren B.H. Trials of intravitreal injections of chemotherapeutic agents in rabbits. Acta Ophthalmologica (Copenh). 1964; 42(4):721-726
DOI: 10.1111/j.1755-3768.1964.tb01723.x
https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1755-3768.1964.tb01723.x

F

Faris B.M., Tarakji M.S., Baghdassarian S.A., To'mey K.F. The role of cryotherapy in the management of early lesions of retinoblastoma. Ann Ophthalmol. 1978;10(8):1005–1008
PMID: 697276
https://pubmed.ncbi.nlm.nih.gov/697276/

Fass D., McCormick B., Abramson D., Ellsworth R. Cobalt60 plaques in recurrent retinoblastoma. Int J Radiat Oncol 1991; 21(3):625–7
doi: 10.1016/0360-3016(91)90679-x
https://pubmed.ncbi.nlm.nih.gov/1869458/

G

Gallie B.L., Budning A., DeBoer G., Thiessen J.J., Koren G., Verjee Z. et al. Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Archives of Ophthalmology.1996. 114:1321–8
DOI: 10.1001/archopht.1996.01100140521001
https://www.ncbi.nlm.nih.gov/pubmed/8906022

Günalp I., Gündüz K., Arslan Y. Retinoblastoma in Turkey: Diagnosis and clinical characteristics. Ophthalmic Genetics.1996. 17:21–7
DOI: 10.3109/13816819609057865
https://www.ncbi.nlm.nih.gov/pubmed/8740694
H

Hadjistilianou T., Greco G., Frezzotti R. Recurrent and new tumours during conservative treatment of bilateral retinoblastoma. Ophthalmic Paediatr Genet. 1991 Jun;12(2):79-84
doi: 10.3109/13816819109023678
https://pubmed.ncbi.nlm.nih.gov/1923317/

Hall L.S., Ceisler E., Abramson D.H. Visual outcomes in children with bilateral retinoblastoma. Journal of American Association for Pediatric Ophthalmology and Strabismus. 1999;3(3): 138–142

Hathirat P, Kunavisarut S, Chuansumrit A, Pochanukul L, Simaroj P, Isarangkura P. Chemotherapy in patients with retinoblastoma. J Med Assoc Thai. 1993 Oct;76 Suppl 2:85-91
PMID: 7823011
https://pubmed.ncbi.nlm.nih.gov/7823011/

Hilgartner H.L. Report of case of double glioma treated with x-ray. 1903. Tex Med. 2005 Jul;101(7):10. PMID: 16152902

Hooper M.L. Is sunlight an aetiological agent in the genesis of retinoblastoma? // British Journal of Cancer. 1999. Vol. 79. P. 1273-1276
DOI: 10.1038/sj.bjc.6690204
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362220/

Howard GM, Ellsworth RM. Differential diagnosis of retinoblastoma. A statistical survey of 500 children. I. Relative frequency of the lesions which simulate retinoblastoma. American Journal of Ophthalmology.1965;60:610-618
https://doi.org/10.1016/j.ophtha.2012.07.067

I

Imhof S.M., Hofman P., Tan K.E. Quantification of lacrimal function after D-shaped field irradiation for retinoblastoma. Br J Ophthalmol. 1993 Aug;77(8):482-4
doi: 10.1136/bjo.77.8.482
PMID: 8025043

https://pubmed.ncbi.nlm.nih.gov/8025043/
Inomata M., Kaneko A. Chemosensitivity profiles of primary and cultured human retinoblastoma cells in a human tumor clonogenic assay. Japanese Journal of Cancer Research. 1987; 78(8): 858-868.
DOI:10.20772/cancersci1985.78.8_858
https://www.ncbi.nlm.nih.gov/pubmed/3115934

K

Karp L.A., Streeten B.W., Cogan D.G. Radiation-induced atrophy of the Meibomian gland. Arch Ophthalmol. 1979 Feb;97(2):303-5
doi: 10.1001/archopht.1979.01020010155013
https://pubmed.ncbi.nlm.nih.gov/550803/

Kaste S.C., Chen G., Fontanesi J., Crom D.B., Pratt C.B. Orbital development in long-term survivors of retinoblastoma // Journal of Clinical Oncology. № 3. P. 1183–1189
DOI: 10.1200/jco.1997.15.3.1183

Kesty, K.R., Campbell R.J., Buettner H. Retinoblastoma: choroidal invasion and patient survival. Invest. Ophthalmol. Vis. Sci. 1983. Vol. 25, (suppl). P.83

Kingston J.E., Hungerford J.L., Madreperla S.A., Plowman P.N. Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Archives of Ophthalmology.1996. 114:1339-43
DOI: 10.1001/archopht.1996.01100140539004
https://www.ncbi.nlm.nih.gov/pubmed/8906024

Knudson AG, Jr. Mutation and cancer: statistical study of retinoblastoma. Proceedings of the National Academy of Sciences of the United States of America. 1971 ;68(4): 820-823
DOI: 10.1073/pnas.68.4.820
https://www.ncbi.nlm.nih.gov/pubmed/5279523

Kogan L, Boniuk M. Causes of enucleation in childhood with special reference to pseudogliomas and unsuspected retinoblastoma.International Ophthalmology Clinics.1962; 2:507-524
https://journals.lww.com/internat-ophthalmology/Citation/1962/06000/Causes_for_Enucleation_in_Childhood_With_Special.14.aspx

L

Lagendijk J.J. A microwave heating technique for the hyperthermic treatment of tumours in the eye, especially retinoblastoma. Physics in Medicine and Biology. 1982;27(11):1313–1324
DOI: 10.1088/0031-9155/27/11/002

Lam B.L., Judisch G.F., Sobol W.M. et al. Visual prognosis in macular retinoblastomas. American journal of ophthalmology. 1990;110(3): 229–232

Lommatzsch P., Vollmar R. A new way in the conservative therapy of intraocular tumors by means of β-irradiation (ruthenium 106) with preservation of vision. // Klin Monatsbl Augenheilkd, 1966, 148:682-699

Lueder G.T., Goyal R. Visual function after laser hyperthermia and chemotherapy for macular retinoblastoma. American journal of ophthalmology. 1996;121(5): 582–584

M

Magramm I., Abramson D.H., Ellsworth R.M. Optic Nerve Involvement in Retinoblastoma. Ophthalmology. 1989. Vol. 96, № 2. P. 217–222
doi: 10.1016/s0161-6420(89)32910-1
https://pubmed.ncbi.nlm.nih.gov/2704542/

Marcus D.M., Craft J.L., Albert D.M. Histopathologic verification of Verhoeff's 1918 irradiation cure of retinoblastoma. Ophthalmology. 1990 Feb;97(2):221-4. PMID: 2326011
doi: 10.1016/s0161-6420(90)32602-7

Martel A., Baillif S., Nahon-esteve S., Gastaud L., Bertolotto C., Roméo B., Mograbi B., Lassalle S., Hofman P. Liquid Biopsy for Solid Ophthalmic Malignancies: An Updated Review and Perspectives. 2020, Cancers, 12(11):3284.
https://doi.org/10.3390/cancers12113284

Matsunaga E., Minoda K., Sasaki M. S. Parental age and seasonal variation in the births of children with sporadic retinoblastoma: a mutation-epidemiologic study // Human Genetics. 1990. Vol. 84. P. 155-158.
DOI: 10.1007/bf00208931
https://www.ncbi.nlm.nih.gov/pubmed/2298450

Messmer E.P. et al. Risk factors for metastases in patients with retinoblastoma. Ophthalmology. 1991. Vol. 98, № 2. P. 136–141
10.1016/S0039-6257(01)00279-X
https://www.researchgate.net/publication/11558247_Risk_Factors_for_Metastasis_in_Retinoblastoma

Migdal C. Bilateral retinoblastoma: the prognosis for vision. British journal of ophthalmology. 1983;67(9): 592–595

Moll A.C., Imhof S.M., Bouter L.M., Tan K.E. Second primary tumors in patients with retinoblastoma. A review of the literature. Ophthalmic Genet. 1997 Mar;18(1):27-34.
doi: 10.3109/13816819709057880
https://pubmed.ncbi.nlm.nih.gov/9134547/

Moll A.C., Imhof S.M., Kuik D.J. et al. High parental age is associated with sporadic hereditary retinoblastoma: the Dutch retinoblastoma register 1862-1994 // Human Genetics. 1996. Vol. 98. P. 109-112
DOI: 10.1007/s004390050168
https://www.ncbi.nlm.nih.gov/pubmed/8682494

Moll A.C., Kuik D.J., Bouter L.M. et al. Incidence and survival of retinoblastoma in the Netherlands: a register based study 1862–1995 // British Journal of Ophthalmology. 1997. Vol. 81. P. 559-562.
DOI: 10.1136/bjo.81.7.559
https://www.ncbi.nlm.nih.gov/pubmed/9290369

Molteno A.C. Efficacy of cryotherapy in retinoblastoma. S Afr Med J. 1976;50(28):1089–1092. PMID: 959914
https://pubmed.ncbi.nlm.nih.gov/959914/

Moore R.F., Stallard H.B., Milner J.G. Retinal glioma treated by radon seeds. // British Journal of Ophthalmology. 1931; 15:673-696

Moscinski L.C. et al. Recommendations for the use of routine bone marrow aspiration and lumbar punctures in the follow-up of patients with retinoblastoma. J. Pediatr. Hematol. Oncol. J Pediatr Hematol Oncol, 1996. Vol. 18, № 2. P. 130–134
https://journals.lww.com/jpho-online/Abstract/1996/05000/Recommendations_for_the_Use_of_Routine_Bone_Marrow.6.aspx

Murphee A.L., Villablanca J.G., Deegan W.F. 3rd, et al. Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch. Ophthalmol. 1996; 114: 1348–56
doi: 10.1001/archopht.1996.01100140548005
https://pubmed.ncbi.nlm.nih.gov/8906025/

N


Namouni F., Doz F., Tanguy M.L. et al. High-dose chemotherapy with Carboplatin, Etoposide and Cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study. // European Journal of Cancer, 1997, vol.33, №14, pp.2368-2375
DOI: 10.1016/s0959-8049(97)10019-3
https://www.ncbi.nlm.nih.gov/pubmed/9616283
P

Parkin D.M., Kramarova E., Drapper G.J. et al. International incidence of childhood cancer // IARC Scientific Publications. 1998. Vol. 2. P. 1-391

Potter P. De, Shields C., Shields J., Singh A. Use of the Hydroxyapatite Ocular Implant in the Pediatric Population // Arch Ophthalmol. 1994. № 2. P. 208–212
DOI:10.1001/ archopht.1994.01090140084028

Pradhan D.G., Sandridge A.L., Mullaney P., Abboud E., Karcioglu Z.A., Kandil A., Mustafa M.M., Gray A.J. Radiation therapy for retinoblastoma: a retrospective review of 120 patients. Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):3-13
doi: 10.1016/s0360-3016(97)00156-9
https://pubmed.ncbi.nlm.nih.gov/9300734/

R

Reese A.B., Ellsworth R.M. The evaluation and current concept of retinoblastoma therapy. Trans Am Acad Ophthalmol Otolaryngol 1963; 67:164–72. PMID: 13973597

Reese A.B., Hyman G.A., Tapley N.D., Forrest A.W. The treatment of retinoblastoma by x ray and triethylene melamine. A.M.A Archives of Ophthalmology.1958. 60:897–906
DOI: 10.1001/archopht.1958
https://www.ncbi.nlm.nih.gov/pubmed/13582334

Rootman J. et al. Invasion of the optic nerve by retinoblastoma: a clinicopathological study. Can. J. Ophthalmol. 1976. Vol. 11, № 2. P. 106–114
https://pubmed.ncbi.nlm.nih.gov/1078326/

S

Sacks J.G., McLennan J.E. Transcranial enucleation for optic nerve tumor. Neurosurgery 1981;9(2):166–8
doi: 10.1227/00006123-198108000-00010
https://www.meta.org/papers/transcranial-enucleation-for-optic-nerve/7266816

Sanders B.M., Draper G.J., Kingston J.E. Retinoblasoma in Great Britain 1969-1980: Incidence, treatment, and survival // British Journal of Ophthalmology. 1988. Vol. 72. N 8. P. 576-583
DOI: 10.1136/bjo.72.8.576
https://www.ncbi.nlm.nih.gov/pubmed/3415951

Seeger R.C., Reynolds C.P. Treatment of high-risk solid tumors of childhood with intensive therapy and autologous bone marrow transplantation. Pediat Clin North Amer. 1991; 38: 393-424
doi: 10.1016/S0031-3955(16)38084-1

Seregard S., Kock E., Trampe E. Intravitreal chemotherapy for recurrent retinoblastoma in an only eye. Br J Ophthalmol 1995; 79(2):194–5
doi: 10.1136/bjo.79.2.194
https://pubmed.ncbi.nlm.nih.gov/7696247/

Shannon C.E.G., Jaeger R., Forster F.M. The Combined Intracranial and Orbital Operation for Bilateral Retinoblastoma. Trans AmOphthalmol Soc 1944;42:326–33.
PMID: 16693356

Shields C.L. et al. Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors. Cancer. 1994. Vol. 73, № 3. P. 692–698
doi: 10.1002/1097-0142(19940201)73:3<692::aid-cncr2820730331>3.0.co;2-8
https://pubmed.ncbi.nlm.nih.gov/8299091/

Shields C.L., De Potter P., Himelstein B.P., Shields J.A., Meadows A.T., Maris J.M. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol. 1996 Nov;114(11):1330-8
doi: 10.1001/archopht.1996.01100140530002
https://pubmed.ncbi.nlm.nih.gov/8906023/

Shields C.L., Santos M.C., Diniz W., Gündüz K., Mercado G., Cater J.R., Shields J.A. Thermotherapy for retinoblastoma. Arch Ophthalmol. 1999 Jul;117(7):885-93
doi: 10.1001/archopht.117.7.885
https://pubmed.ncbi.nlm.nih.gov/10408452/

Shields C.L., Shields J.A., DePotter P., Himelstein B.P., Meadows A.T. The effect of chemoreduction on retinoblastoma-induced retinal detachment.Journal of Pediatric Ophthalmology and Strabismus.1997. 34:165–9
https://www.ncbi.nlm.nih.gov/pubmed/9168421

Shields C.L., Shields J.A., De Potter P., Minelli S., Hernandez C., Brady L.W., Cater J.R. Plaque Radiotherapy in the Management of Retinoblastoma. Use as a primary and secondary treatment. Ophthalmology 1993;100(2):216–24
doi: 10.1016/s0161-6420(93)31667-2
https://pubmed.ncbi.nlm.nih.gov/8437830/

Shields C.L., Shields J.A., Kiratli H., De Potter P.V. Treatment of retinoblastoma with indirect ophthalmoscope laser photocoagulation. J Pediatr Ophthalmol Strabismus. 1995 Sep-Oct;32(5):317-22
https://pubmed.ncbi.nlm.nih.gov/8531038/

Shields C.L., Shields J.A., Minelli S., De Potter P., Hernandez C., Cater J., Brady L. Regression of Retinoblastoma After Plaque Radiotherapy. Am J Ophthalmol 1993;115(2):181–7
doi: 10.1016/s0002-9394(14)73922-4
https://pubmed.ncbi.nlm.nih.gov/8430727/

Shields C.L., Shields J.A., Needle M. et al. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. // Opthalmology, 1997, vol.104, №12, pp. 2101-2111
DOI: 10.1016/s0161-6420(97)30053-0
https://www.ncbi.nlm.nih.gov/pubmed/9400771

Shields C.L., Shields J.A., Shah P. Retinoblastoma in older children. Ophthalmology. 1991 Mar;98(3):395-9
doi: 10.1016/s0161-6420(91)32283-8
https://pubmed.ncbi.nlm.nih.gov/2023762/

Shields J.A., Shields C.L., De Potter P., Hernandez J.C., Brady L.W. Plaque Radiotherapy for Residual or Recurrent Retinoblastoma in 91 Cases. J Pediatr Ophthalmol Strabismus, 1994; 31(4):242–5.
PMID: 7807301
https://pubmed.ncbi.nlm.nih.gov/7807301/

Shields J.A., Shields C.L., Sivalingam V. Decreasing frequency of enucleation in patients with retinoblastoma. Am J Ophthalmol. 1989 Aug 15;108(2):185-8
doi: 10.1016/0002-9394(89)90015-9.
https://pubmed.ncbi.nlm.nih.gov/2757099/

Shields J., Shields C. (Edd.) Intraocular tumors: A text and atlas. Philadelphia, Saunders. 1992

Spraul C.W., Lim J.I., Lambert S.R., Grossniklaus H.E. Retinoblastoma Recurrence after Iodine 125 Plaque Application. Retina 1996; 16(2):135–8
doi: 10.1097/00006982-199616020-00009
https://pubmed.ncbi.nlm.nih.gov/8724958/

Stallard H.B. Comparative Value of Radium and Deep X Rays in the Treatment of Retinoblastoma. Br J Ophthalmol 1952; 36(6):313–24
doi: 10.1136/bjo.36.6.313

Stallard H.B. Radiotherapy of malignant intra-ocular neoplasms. Br J Ophthalmol 1948;32(9):618–39
doi: 10.1136/bjo.32.9.618

W

Weiss A.H., Karr D.J., Kalina R.E. et al. Visual outcomes of macular retinoblastoma after external beam radiation therapy. Ophthalmology. 1994;101(7): 1244–1249

White L. Chemotherapy for retinoblastoma: where do we go from here?: a review of published literature and meeting abstracts, including discussions during the Vth International Symposium on Retinoblastoma, Oct 1991. Ophthalmic Paediatr Genet. 1991; 12(3): 115-130
doi: 10.3109/13816819109029393

Wilson T.W., Chan H.S., Moselhy G.M., Heydt D.D. Jr., Frey C.M., Gallie B.L. Penetration of chemotherapy into vitreous is increased by cryotherapy and cyclosporine in rabbits. Arch Ophthalmol. 1996 Nov;114(11):1390-5
doi: 10.1001/archopht.1996.01100140590011
https://pubmed.ncbi.nlm.nih.gov/8906030/

Winther J., Olsen J., Browns P. Risk of Nonocular Cancer Among Retinoblastoma Patients and Their Parents. A Population-Based Study in Denmark, 1943-1984 // Cancer. 1988. Vol. 62. P. 1458-1462
DOI:10.1007/bf00206747
https://link.springer.com/article/10.1007%2FBF00206747

Wong F.L., Boice J.D. Jr., Abramson D.H. et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA. 1997 Oct 15;278(15):1262-7
doi: 10.1001/jama.278.15.1262
https://pubmed.ncbi.nlm.nih.gov/9333268/

Y

Yu N., Chen P., Wang Q., Liang M., Qiu J., Zhou P., Yang M., Yang P., Wu Y., Han X., Ge J., Zhuang J., Yu K. Histone deacetylase inhibitors differentially regulate c-Myc expression in retinoblastoma cells. Oncol. Lett. 2020, 19, 460-468.
https:// doi.org/10.3892/ol.2019.11111
Вам понравилась страница?